Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Starts ESSA Bancorp (ESSA) at Buy
-
Capnia (CAPN) Announces $10M Convertible Preferred Private placement
-
Capnia Announces Private Placement of Up to $10 Million of Convertible Preferred Stock and Warrants
-
Maxim Group Starts Check-Cap (CHEK) at Buy; $18 PT
-
Applied DNA Sciences' (APDN) Price Target Raised to $13 at Maxim Group
-
Wedbush Securities' Equity Sales and Trading Targets Growth, Expands Team with New Members
-
PlacementTracker Publishes Third Quarter 2015 PIPE Market League Tables
-
bluebird bio (BLUE) Bullish View Reiterated at Maxim Group Following Update from Management
-
Maxim Group Upgrades Tyler Tech (TYL) to Buy
-
Aeterna Zentaris (AEZS) Places Net Cashless Exercise Cap on Series B Common Warrants
-
Aeterna Zentaris Announces Amendment to Series B Warrants
-
Maxim Group Starts Buffalo Wild Wings, Inc. (BWLD) at Hold
-
Intec Pharma Ltd. Announces Partial Exercise of Underwriters Option to Purchase Additional Ordinary Shares
-
Maxim Group Starts Intec Pharma Ltd. (NTEC) at Buy
-
HP to cut up to 33,300 jobs over next three years
-
Maxim Group Starts Neurometrix Inc. (NURO) at Buy
-
Maxim Group Starts Texas Roadhouse (TXRH) at Buy
-
Maxim Lifts PT on Inovio (INO) to $23 Following Initiation of Dosing in PENNVAX-GP Phase 1
-
Paragon Shipping Inc. Announces At-The-Market Offering Of Up To $4.0 Million Of Common Shares
-
Maxim Group Starts Suffolk Bancorp (SUBK) at Buy
-
Cesca Therapeutics Secures $15 Million Financing From Institutional Life Sciences Fund
-
Maxim Group Starts First Community Financial (FCFP) at Buy
-
Notable Analyst Rating Changes 8/28: (HBAN) (MDCO) (ARCC) Upgraded; (MTGE) (TDC) (BWA) Downgraded
-
Maxim Group Starts Domino's Pizza (DPZ) at Buy
-
Maxim Group Starts Dunkin' Brands (DNKN) at Buy
-
Maxim Group Starts Majesco (MJCO) at Buy
-
Manhattan Scientifics, Inc. Announces Stock Repurchase Program
-
IFAN Financial, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
-
Maxim Group Starts Access National Corp. (ANCX) at Buy
-
Benitec Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ
-
Maxim Group and Certent Enhance Technology for Equity Plan Administration
-
Cantor Fitzgerald Continues to Build Equity Research Team with Three Hires
-
Maxim Group Starts Zoe's Kitchen (ZOES) at Buy
-
Maxim Group Starts Panera Bread (PNRA) at Hold
-
Maxim Group Starts Chipotle Mexican Grill (CMG) at Hold
-
Benitec Announces Pricing Of An Initial Public Offering In The United States With Listing On NASDAQ
-
Odeon Capital Group LLC Announces Product and Research Expansion
-
Maxim Group Starts General Employment Enterprises (JOB) at Buy
-
Brainstorm Cell Therapeutics (BCLI) Completes Nurown Phase 2 Enrollment, Continues Executing Business Plan - Maxim
-
Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering
-
Cytori Therapeutics (CYTX) PT Trimmed to $5 at Maxim Group; 'Buy' Maintained
-
Crescent Harbor Modern Adds New ET2 Lighting Products to its Online Store
-
Sucampo (SCMP) PT Raised to $25 at Maxim Group
-
Maxim Group Downgrades TICC Capital (TICC) to Hold
-
Intec Pharma (NTEC) IPO Opens Flat
-
Intec Pharma (NTEC) Prices 5.03M Ordinary Share IPO at $6/Share
-
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering
-
Chardan Capital Markets, LLC Expands Equity Division With Appointment Of Jeff Sklar, Managing Director and Head Of Institutional Sales
-
Matters Regarding UBIC's Acquisition of Shares of EvD, Inc. (to Become Our Subsidiary)
-
Matters Regarding UBIC's Acquisition of Shares of EvD, Inc. (to Become Our Subsidiary)

